News & Updates

Paclitaxel-coated devices do not increase mortality risk

14 Nov 2023 by

An updated patient-level meta-analysis refutes claims that paclitaxel-coated devices for femoropopliteal interventional procedures heighten the risk of death. The recent study presented at TCT 2023 has found no association between exposure to paclitaxel and mortality.

Paclitaxel-coated devices do not increase mortality risk

14 Nov 2023

Shorter outshines longer DAPT for ACS patients following DES implantation

14 Nov 2023 by

In patients treated with drug-eluting stents (DES) for acute coronary syndrome (ACS), stopping aspirin within a month of dual antiplatelet therapy (DAPT) and continuing with ticagrelor alone outdid a 12-month DAPT regimen with ticagrelor and aspirin, findings from the T-PASS trial have shown.

Shorter outshines longer DAPT for ACS patients following DES implantation

14 Nov 2023

Women fare better than men after Impella-assisted HR PCI

13 Nov 2023 by

Women undergoing high-risk percutaneous coronary intervention (HR PCI) appear to have better survival outcomes following hospital discharge compared with men, despite being older and having a more complex coronary artery disease, according to data from the IMPELLA-PL registry.

Women fare better than men after Impella-assisted HR PCI

13 Nov 2023

Deep learning-enabled echocardiographic readings help predict CV outcomes

13 Nov 2023

Deep learning interpretation of echocardiographic images demonstrates accurate readings of standard measures of left heart structure and function, which are predictive of cardiovascular (CV) outcomes, reports a recent study.

Deep learning-enabled echocardiographic readings help predict CV outcomes

13 Nov 2023

Is TAVR better than surgery for aortic stenosis patients?

13 Nov 2023 by

Treatment with transcatheter aortic-valve replacement (TAVR) or surgery in low-risk patients with severe, symptomatic aortic stenosis results in similar and low clinical event rates at 5 years, according to the results of the PARTNER 3 study.

Is TAVR better than surgery for aortic stenosis patients?

13 Nov 2023

TTVR system holds promise for severe tricuspid regurgitation

13 Nov 2023 by

Transcatheter tricuspid valve replacement (TTVR) using the EVOQUE system was feasible and had an acceptable safety profile in patients with severe tricuspid regurgitation (TR), according to initial data from the pivotal TRISCEND II trial.

TTVR system holds promise for severe tricuspid regurgitation

13 Nov 2023

Women more likely to undergo TAVR, at higher risk of in-hospital death

12 Nov 2023

Use of transcatheter aortic valve replacement (TAVR) is still not common among young patients, being restricted only to those at increased risk, reports a study in France. Significant differences in sex appear in patient demographics, selection of aortic valve replacement (AVR) modality, and patient outcomes.

Women more likely to undergo TAVR, at higher risk of in-hospital death

12 Nov 2023

Sugar, except from fruits and veggies, ups risk of CHD

11 Nov 2023

Consumption of total sugar, total glucose equivalents (TGE), added sugar, and fructose from added sugar and juice appears to increase the risk of coronary heart disease (CHD), reveals a study. However, intake of total fructose equivalents (TFE) and fructose from fruits and vegetables does not.

Sugar, except from fruits and veggies, ups risk of CHD

11 Nov 2023

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

11 Nov 2023

Clinical presentation is more severe and survival much lower among patients with right heart thrombus and pulmonary embolism, who also require more advanced therapies, compared with those without a concomitant pulmonary embolism, a study has found. Thrombus mobility and size contribute to the development of concomitant pulmonary embolism.

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

11 Nov 2023

RADIANCE: BP lowering with renal denervation maintained at 6 months

11 Nov 2023 by

Across the RADIANCE trials, individuals treated with renal denervation remain to have a lower medication burden throughout the 6-month follow-up period even after the reintroduction of blood pressure (BP)-lowering drugs.

RADIANCE: BP lowering with renal denervation maintained at 6 months

11 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Paclitaxel-coated devices do not increase mortality risk

Paclitaxel-coated devices do not increase mortality risk

Shorter outshines longer DAPT for ACS patients following DES implantation

Shorter outshines longer DAPT for ACS patients following DES implantation

Women fare better than men after Impella-assisted HR PCI

Women fare better than men after Impella-assisted HR PCI

Deep learning-enabled echocardiographic readings help predict CV outcomes

Deep learning-enabled echocardiographic readings help predict CV outcomes

Is TAVR better than surgery for aortic stenosis patients?

Is TAVR better than surgery for aortic stenosis patients?

TTVR system holds promise for severe tricuspid regurgitation

TTVR system holds promise for severe tricuspid regurgitation

Women more likely to undergo TAVR, at higher risk of in-hospital death

Women more likely to undergo TAVR, at higher risk of in-hospital death

Sugar, except from fruits and veggies, ups risk of CHD

Sugar, except from fruits and veggies, ups risk of CHD

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

RADIANCE: BP lowering with renal denervation maintained at 6 months

RADIANCE: BP lowering with renal denervation maintained at 6 months